HRP20040051A2 - Metabolic controlled fermentation process for pseudomonic acid production - Google Patents

Metabolic controlled fermentation process for pseudomonic acid production Download PDF

Info

Publication number
HRP20040051A2
HRP20040051A2 HR20040051A HRP20040051A HRP20040051A2 HR P20040051 A2 HRP20040051 A2 HR P20040051A2 HR 20040051 A HR20040051 A HR 20040051A HR P20040051 A HRP20040051 A HR P20040051A HR P20040051 A2 HRP20040051 A2 HR P20040051A2
Authority
HR
Croatia
Prior art keywords
fermentation
process according
fermentation process
acid
mixture
Prior art date
Application number
HR20040051A
Other languages
English (en)
Croatian (hr)
Inventor
Gabor Balogh
Eva Gulyas
Janos Erdei
Peter Seress
Original Assignee
Biogal Gyogyszergyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogal Gyogyszergyar filed Critical Biogal Gyogyszergyar
Publication of HRP20040051A2 publication Critical patent/HRP20040051A2/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • C12P17/162—Heterorings having oxygen atoms as the only ring heteroatoms, e.g. Lasalocid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HR20040051A 2001-06-21 2002-06-21 Metabolic controlled fermentation process for pseudomonic acid production HRP20040051A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29992701P 2001-06-21 2001-06-21
PCT/US2002/020044 WO2003000910A2 (en) 2001-06-21 2002-06-21 Metabolic controlled fermentation process for pseudomonic acid production

Publications (1)

Publication Number Publication Date
HRP20040051A2 true HRP20040051A2 (en) 2004-10-31

Family

ID=23156895

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20040051A HRP20040051A2 (en) 2001-06-21 2002-06-21 Metabolic controlled fermentation process for pseudomonic acid production

Country Status (16)

Country Link
US (1) US7439045B2 (cs)
EP (1) EP1409703A4 (cs)
JP (1) JP2005518780A (cs)
KR (1) KR20040026669A (cs)
AU (1) AU2002345856A1 (cs)
CA (1) CA2448547A1 (cs)
CZ (1) CZ200467A3 (cs)
DE (1) DE02744598T1 (cs)
ES (1) ES2228294T1 (cs)
HR (1) HRP20040051A2 (cs)
HU (1) HUP0500797A2 (cs)
MX (1) MXPA03012044A (cs)
PL (1) PL374255A1 (cs)
SK (1) SK412004A3 (cs)
TR (1) TR200403211T3 (cs)
WO (1) WO2003000910A2 (cs)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2460970C (en) * 2001-12-28 2005-10-18 Biogal Gyogyszergyar Rt Processes for preparing crystalline and amorphous mupirocin calcium
IL150907A (en) * 2002-07-25 2007-07-04 Stephan Cherkez Process for the preparation of stable amorphous calcium pseudomonate
WO2005117837A1 (en) * 2004-06-01 2005-12-15 Teva Gyógyszergyár Zàrtköruen Muködo Rèszvènytàrsasàg Process for preparation of amorphous form of a drug
CA2598565C (en) 2005-02-21 2013-06-25 Alpharma Aps Purification of mupirocin
CN108277243B (zh) * 2018-01-19 2021-03-12 浙江瑞邦药业股份有限公司 一种假单胞菌酸a的制备方法
CN108949845B (zh) * 2018-08-08 2021-08-10 福建康鸿生物科技有限公司 一种发酵培养基及由发酵培养基制备莫匹罗星的方法
EP4273256A4 (en) * 2021-02-07 2025-07-16 Hangzhou Zhongmeihuadong Pharmaceutical Co Ltd FERMENTATION PROCESS FOR MUPIROCIN

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1643240A1 (de) * 1966-09-16 1971-06-24 Boehringer Sohn Ingelheim Verfahren zur Herstellung neuer racemischer oder optisch aktiver 1-Phenoxy-2-aminoalkane
US3977943A (en) * 1971-06-12 1976-08-31 Beecham Group Limited Antibiotics
GB1395907A (en) * 1971-06-12 1975-05-29 Beecham Group Ltd Antibiotics
US4071536A (en) * 1971-06-12 1978-01-31 Beecham Group Limited Antibiotics
JPS5270083A (en) 1975-12-04 1977-06-10 Yoshitomi Pharmaceut Ind Ltd Manufacture of an antibiotics, trans-pseudomonic acid
GB1577730A (en) 1976-10-23 1980-10-29 Beecham Group Ltd Treatment of infections with pseudomonicacid salts or esters thereof
GB1577545A (en) 1977-07-27 1980-10-22 Beecham Group Ltd Treatment of swine dysenter
CA1103264A (en) 1977-09-30 1981-06-16 Norman H. Rogers Purification of pseudomonic acid
CA1115699A (en) * 1978-05-20 1982-01-05 Alan D. Curzons Lithium pseudomonate and its preparation
CA1196284A (en) * 1982-05-28 1985-11-05 Joshua Oduro-Yeboah Pharmaceutical formulations
GB8415579D0 (en) * 1984-06-19 1984-07-25 Beecham Group Plc Compounds
GB8428952D0 (en) 1984-11-16 1984-12-27 Beecham Group Plc Formulations
GB8530796D0 (en) * 1985-12-13 1986-01-22 Beecham Group Plc Pharmaceutical composition
IE59628B1 (en) 1986-06-26 1994-03-09 Beecham Group Plc Treatment of fungal infections
US5594026A (en) * 1990-12-11 1997-01-14 Smithkline Beecham Group P.L.C. Polymorphs of crystalline mupirocin
US5292892A (en) * 1991-05-07 1994-03-08 Sankyo Company, Limited Anti-bacterial compound and pharmaceutical compositions thereof
US6503881B2 (en) * 1996-08-21 2003-01-07 Micrologix Biotech Inc. Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics
CN1239427A (zh) * 1996-10-01 1999-12-22 史密丝克莱恩比彻姆公司 Mupirocin在制备用于治疗与病原生物体鼻咽建群有关的细菌感染的药物中的应用
US6231875B1 (en) * 1998-03-31 2001-05-15 Johnson & Johnson Consumer Companies, Inc. Acidified composition for topical treatment of nail and skin conditions
YU55501A (sh) 1999-02-03 2003-07-07 Biogal Gyogyszergyar Rt. Proces za izolaciju pseudomonične kiseline a iz kompleksa pseudomonične kiseline sadržanog u kulturnom bujonu
KR20010113674A (ko) 1999-02-03 2001-12-28 자노스 바르가, 테레지아 밀레 미생물적 방법에 의하여 슈도몬산 ａ 항생제를 제조하는방법
US6335023B1 (en) * 1999-06-30 2002-01-01 Ruey J. Yu Oligosaccharide aldonic acids and their topical use
US6528086B2 (en) * 1999-09-28 2003-03-04 Zars, Inc. Methods and apparatus for drug delivery involving phase changing formulations
IL137363A (en) 2000-07-18 2005-12-18 Agis Ind 1983 Ltd Pharmaceutical compositions containing mupirocin
IL150907A (en) 2002-07-25 2007-07-04 Stephan Cherkez Process for the preparation of stable amorphous calcium pseudomonate

Also Published As

Publication number Publication date
JP2005518780A (ja) 2005-06-30
WO2003000910A2 (en) 2003-01-03
HUP0500797A2 (en) 2007-06-28
SK412004A3 (en) 2004-12-01
US20030027292A1 (en) 2003-02-06
MXPA03012044A (es) 2004-06-17
EP1409703A4 (en) 2004-08-18
AU2002345856A1 (en) 2003-01-08
TR200403211T3 (tr) 2005-02-21
PL374255A1 (en) 2005-10-03
EP1409703A2 (en) 2004-04-21
WO2003000910A3 (en) 2003-04-24
CZ200467A3 (cs) 2004-10-13
ES2228294T1 (es) 2005-04-16
KR20040026669A (ko) 2004-03-31
US7439045B2 (en) 2008-10-21
DE02744598T1 (de) 2005-03-31
CA2448547A1 (en) 2003-01-03

Similar Documents

Publication Publication Date Title
DE68927103T2 (de) Verfahren zur herstellung von gamma- und delta-lactonen
CN101225411A (zh) 生物合成生产混合长链二元酸的新方法
HRP20040051A2 (en) Metabolic controlled fermentation process for pseudomonic acid production
CN101538599B (zh) 提高脱氮假单胞杆菌维生素b12产量的方法
CN117126904B (zh) 一种循环持续发酵鼠李糖脂的方法
CA2719581C (en) Improved fermentation process for higher yield coefficient of lipase-inhibitor with respect to consumed fatty acid
CN1128224C (zh) 生产脂抑制素和四氢脂抑制素的方法
CN104388501B (zh) 一种应用生物酶的红霉素制备方法
DE112018006584T5 (de) Verfahren zur fermentativen Herstellung von oxidiertem Coenzym Q10 sowie daraus hergestelltes hochgehaltiges oxidiertes Coenzym Q10
KR101579766B1 (ko) 일종의 사이클릭 리포펩티드 화합물의 제조방법
CN117327747B (zh) 采用微生物发酵生产d-泛酸的方法
TWI627278B (zh) 生產l-組胺酸之麩胺酸棒狀桿菌變異株與使用其生產l-組胺酸之方法
CN118109527A (zh) 一种采用构巢曲霉发酵产5-氨基乙酰丙酸的工艺
CN109576196A (zh) 一种生产多拉菌素的发酵培养基及多拉菌素的生产方法
EP1613759B1 (en) Fermentation processes with low concentrations of carbon- and nitrogen-containing nutrients
EP0410430A2 (de) Verfahren zur diskontinuierlichen Herstellung von L-Carnitin auf mikrobiologischem Weg
Adamczak et al. Properties and yield of synthesis of mannosylerythritol lipids by Candida antarctica
CN110468051A (zh) 一种k252a发酵培养基及其制备方法
NO326120B1 (no) Mikroorganisme som produserer 5-aminolevulinsyre og fremgangsmåte for fremstilling av 5-aminolevulinsyre ved anvendelse derav
JP2002281993A (ja) シキミ酸の製造方法
Pospíšil et al. Changes in fatty acid branching and unsaturation of Streptomyces cinnamonensis as a response to NaCl concentration
KR920005976B1 (ko) 미생물에 의한 l-글루타민의 제조방법
CN116814714A (zh) 一种提高海南霉素发酵水平的补料方法
CN114807275A (zh) 一种提高普那霉素产量的发酵方法
SU1557165A1 (ru) Способ получени биологически активных веществ

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
PNAN Change of the applicant name, address/residence

Owner name: TEVA GYOGYSZERGYAR RESZVENYTARSASAG, HU

ODRP Renewal fee for the maintenance of a patent

Payment date: 20050606

Year of fee payment: 4

OBST Application withdrawn